e-learning
resources
Milan 2017
Tuesday, 12.09.2017
COPD biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peripheral Blood Eosinophils as Marker of Sputum Eosinophilia and Outocome of COPD Exacerbation
E. Jusufovic (Tuzla, Bosnia and Herzegovina)
Source:
International Congress 2017 – COPD biomarkers
Session:
COPD biomarkers
Session type:
Thematic Poster
Number:
3606
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Jusufovic (Tuzla, Bosnia and Herzegovina). Peripheral Blood Eosinophils as Marker of Sputum Eosinophilia and Outocome of COPD Exacerbation. 3606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Diagnosing Pulmonary Tuberculosis by Pooling Induced Sputum
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Community-Acquired Pneumonia with Evolving Cavitation and Peripheral Eosinophilia
Source: International Congress 2018 – CC8 Non-resolving pneumonia
Year: 2018
Predictors of sputum and BAL eosinophilia in the Wessex Severe Asthma Cohort
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Microbiome Characteristics of Induced Sputum compared to Bronchial Fluid and Upper Airway Samples
Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives
Year: 2018
LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Relation of sputum and BAL neutrophils to the development of Chronic Lung Allograft Dysfunction after lung transplantation
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Distribution of Blood Eosinophils Among Patients with COPD in Primary Care
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017
Ozone and Sensitization Alter Airway and Nerve-associated Eosinophils
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Peripheral blood eosinophilia and clinical phenotype in Bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Distinct Tryptase and CPA3-positive Basophil Phenotypes in Healthy Individuals, Asthma, and COPD
Source: International Congress 2017 – New immune markers for asthma and COPD
Year: 2017
Late Breaking Abstract - Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Induced sputum
Source: Annual Congress 2009 - PG8 Asthma: monitoring airway disease
Year: 2009
Induced sputum
Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Year: 2003
Relationship between Neutrophilic Airway Inflammation and Airway Colonisation in non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
LATE-BREAKING ABSTRACT: Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in COPD?
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Sputum neutrophil differential cell count in health and relationship to disease severity in asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept